$ARWR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARROWHEAD PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ARROWHEAD PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Sell | S | 10.29 | 15,000 | 154,292 | 0 | 15 K to 0 (-100.00 %) |
Jan 06 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Buy | M | 2.62 | 2,500 | 6,550 | 15,000 | 12.5 K to 15 K (+20.00 %) |
Jan 06 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Buy | M | 5.19 | 2,500 | 12,975 | 12,500 | 10 K to 12.5 K (+25.00 %) |
Jan 06 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Buy | M | 4.60 | 10,000 | 46,000 | 10,000 | 0 to 10 K |
Oct 15 2013 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Grant | A | 7.58 | 1,200 | 9,096 | 2,220 | 1 K to 2.2 K (+117.65 %) |
Sep 24 2013 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 4.75 | 7,000 | 33,250 | 82,500 | |
Sep 24 2013 | ARWR | ARROWHEAD PHARMACE ... | PERRY MICHAEL S | Director | Option Exercise | A | 4.75 | 7,000 | 33,250 | 77,000 | |
Sep 24 2013 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Option Exercise | A | 4.75 | 7,000 | 33,250 | 72,000 | |
Sep 24 2013 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 4.75 | 7,000 | 33,250 | 75,000 | |
Sep 24 2013 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Option Exercise | A | 4.75 | 20,000 | 95,000 | 278,000 | |
Sep 24 2013 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | A | 4.75 | 40,000 | 190,000 | 386,000 | |
Sep 24 2013 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Option Exercise | A | 4.75 | 69,991 | 332,457 | 726,466 | |
May 08 2013 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Option Exercise | A | 2.01 | 200,000 | 402,000 | 656,475 | |
May 08 2013 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | A | 2.01 | 170,000 | 341,700 | 346,000 | |
May 08 2013 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Option Exercise | A | 2.01 | 90,000 | 180,900 | 258,000 | |
May 08 2013 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Option Exercise | A | 2.01 | 5,000 | 10,050 | 65,000 | |
May 08 2013 | ARWR | ARROWHEAD PHARMACE ... | PERRY MICHAEL S | Director | Option Exercise | A | 2.01 | 5,000 | 10,050 | 70,000 | |
May 08 2013 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 2.01 | 5,000 | 10,050 | 75,500 | |
Mar 25 2013 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Option Exercise | A | 2.19 | 20,000 | 43,800 | 60,000 | |
Mar 25 2013 | ARWR | ARROWHEAD PHARMACE ... | PERRY MICHAEL S | Director | Option Exercise | A | 2.19 | 15,000 | 32,850 | 65,000 | |
Mar 25 2013 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 2.19 | 15,000 | 32,850 | 68,000 | |
Mar 25 2013 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 2.19 | 15,000 | 32,850 | 70,500 | |
Oct 02 2012 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | A | 2.62 | 35,000 | 91,700 | 176,000 | |
Oct 02 2012 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Option Exercise | A | 2.62 | 50,000 | 131,000 | 456,475 | |
Oct 02 2012 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Option Exercise | A | 2.62 | 25,000 | 65,500 | 168,000 | |
Oct 02 2012 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 2.62 | 10,000 | 26,200 | 55,500 | |
Oct 02 2012 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 2.62 | 10,000 | 26,200 | 53,000 | |
Oct 02 2012 | ARWR | ARROWHEAD PHARMACE ... | PERRY MICHAEL S | Director | Option Exercise | A | 2.62 | 10,000 | 26,200 | 50,000 | |
Oct 02 2012 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Option Exercise | A | 2.62 | 10,000 | 26,200 | 40,000 | |
Feb 21 2012 | ARWR | ARROWHEAD PHARMACE ... | PERRY MICHAEL S | Director | Option Exercise | A | 5.19 | 15,000 | 77,850 | 40,000 | |
Feb 21 2012 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 5.19 | 15,000 | 77,850 | 32,000 | |
Feb 21 2012 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 5.19 | 15,000 | 77,850 | 29,500 | |
Feb 21 2012 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Option Exercise | A | 5.19 | 170,000 | 882,300 | 406,475 | |
Feb 21 2012 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | A | 5.19 | 110,000 | 570,900 | 141,000 | |
Feb 21 2012 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Option Exercise | A | 5.19 | 83,000 | 430,770 | 143,000 | |
Oct 24 2011 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Option Exercise | A | 0.46 | 150,000 | 69,000 | 2,364,750 | |
Oct 24 2011 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Option Exercise | A | 0.46 | 150,000 | 69,000 | 600,000 | |
Aug 10 2011 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 0.45 | 40,000 | 18,000 | 280,000 | |
Aug 10 2011 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 0.45 | 40,000 | 18,000 | 305,000 | |
Aug 31 2010 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Buy | P | 0.89 | 10,000 | 8,900 | 341,729 | 331.7 K to 341.7 K (+3.01 %) |
Aug 30 2010 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Buy | P | 0.89 | 10,000 | 8,900 | 331,729 | 321.7 K to 331.7 K (+3.11 %) |
Aug 30 2010 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Buy | P | 0.89 | 15,000 | 13,350 | 15,000 | 0 to 15 K |
Aug 17 2010 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Option Exercise | A | 0.99 | 500,000 | 495,000 | 2,214,750 | |
Aug 17 2010 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Option Exercise | A | 0.99 | 120,000 | 118,800 | 450,000 | |
Mar 08 2010 | ARWR | ARROWHEAD PHARMACE ... | STEWART R BRUCE | Executive Chairman | Option Exercise | A | 0.52 | 250,000 | 130,000 | 872,000 | |
Mar 08 2010 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 0.52 | 80,000 | 41,600 | 200,000 | |
Mar 08 2010 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | A | 0.52 | 55,000 | 28,600 | 225,000 | |
Mar 08 2010 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 0.52 | 55,000 | 28,600 | 225,000 | |
Mar 08 2010 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Option Exercise | A | 0.52 | 563,250 | 292,890 | 1,714,750 | |
Oct 13 2009 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 0.51 | 70,000 | 35,700 | 170,000 | |
Oct 13 2009 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | A | 0.51 | 70,000 | 35,700 | 170,000 | |
Oct 13 2009 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 0.51 | 70,000 | 35,700 | 120,000 | |
Oct 13 2009 | ARWR | ARROWHEAD PHARMACE ... | STEWART R BRUCE | Executive Chairman | Option Exercise | A | 0.51 | 322,000 | 164,220 | 622,000 | |
Oct 13 2009 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Option Exercise | A | 0.51 | 1,126,500 | 574,515 | 1,151,500 | |
Aug 24 2009 | ARWR | ARROWHEAD PHARMACE ... | McDonnel Paul Clayton | CFO (former) | Option Exercise | J | 5.00 | 100,000 | 500,000 | 95,000 | |
Aug 24 2009 | ARWR | ARROWHEAD PHARMACE ... | McDonnel Paul Clayton | CFO (former) | Option Exercise | J | 4.61 | 100,000 | 461,000 | 195,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | J | 2.55 | 20,000 | 51,000 | 100,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | J | 3.93 | 20,000 | 78,600 | 120,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | J | 5.24 | 25,000 | 131,000 | 140,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | J | 5.02 | 10,000 | 50,200 | 165,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | J | 2.52 | 50,000 | 126,000 | 175,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | J | 2.55 | 20,000 | 51,000 | 100,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | J | 3.93 | 20,000 | 78,600 | 120,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | J | 5.24 | 25,000 | 131,000 | 140,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | J | 5.02 | 10,000 | 50,200 | 165,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | J | 2.52 | 50,000 | 126,000 | 175,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | J | 2.55 | 20,000 | 51,000 | 50,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | J | 3.93 | 20,000 | 78,600 | 70,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | J | 5.24 | 25,000 | 131,000 | 90,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | J | 5.02 | 10,000 | 50,200 | 115,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | J | 2.52 | 50,000 | 126,000 | 125,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | STEWART R BRUCE | Executive Chairman | Option Exercise | A | 2.13 | 50,000 | 106,500 | 875,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Option Exercise | J | 3.92 | 2,000,000 | 7,840,000 | 25,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | STEWART R BRUCE | Executive Chairman | Option Exercise | J | 4.34 | 250,000 | 1,085,000 | 300,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | STEWART R BRUCE | Executive Chairman | Option Exercise | J | 5.24 | 75,000 | 393,000 | 550,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | STEWART R BRUCE | Executive Chairman | Option Exercise | J | 2.52 | 250,000 | 630,000 | 625,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | A | 0.49 | 40,000 | 19,600 | 225,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 0.49 | 40,000 | 19,600 | 175,000 | |
Aug 19 2009 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 0.49 | 40,000 | 19,600 | 225,000 | |
Jan 27 2009 | ARWR | ARROWHEAD PHARMACE ... | STEWART R BRUCE | President | Option Exercise | A | 2.13 | 50,000 | 106,500 | 875,000 | |
Jan 23 2009 | ARWR | ARROWHEAD PHARMACE ... | McDonnel Paul Clayton | Chief Financial Off ... | Option Exercise | A | 2.13 | 50,000 | 106,500 | 250,000 | |
Jan 23 2009 | ARWR | ARROWHEAD PHARMACE ... | McDonnel Paul Clayton | Chief Financial Off ... | Option Exercise | A | 1.11 | 45,000 | 49,950 | 295,000 | |
Jan 23 2009 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Option Exercise | A | 2.13 | 25,000 | 53,250 | 2,025,000 | |
Jan 23 2009 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 2.55 | 20,000 | 51,000 | 185,000 | |
Jan 23 2009 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 2.55 | 20,000 | 51,000 | 135,000 | |
Jan 23 2009 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | A | 2.55 | 20,000 | 51,000 | 185,000 | |
Aug 25 2008 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Option Exercise | P | 2.00 | 164,000 | 328,000 | 164,000 | |
Aug 25 2008 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Buy | P | 0.00 | 164,000 | 0 | 164,000 | 0 to 164 K |
Dec 07 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 3.86 | 1,000 | 3,860 | 10,200 | 11.2 K to 10.2 K (-8.93 %) |
Nov 06 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 3.91 | 1,000 | 3,910 | 11,200 | 12.2 K to 11.2 K (-8.20 %) |
Oct 09 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 5.00 | 1,000 | 5,000 | 12,200 | 13.2 K to 12.2 K (-7.58 %) |
Sep 06 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 5.04 | 1,000 | 5,040 | 13,200 | 14.2 K to 13.2 K (-7.04 %) |
Aug 08 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 5.44 | 1,000 | 5,440 | 14,200 | 15.2 K to 14.2 K (-6.58 %) |
Jul 06 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 4.88 | 1,000 | 4,880 | 15,200 | 16.2 K to 15.2 K (-6.17 %) |
Jun 06 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 7.21 | 1,000 | 7,210 | 16,200 | 17.2 K to 16.2 K (-5.81 %) |
May 09 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 7.00 | 1,000 | 7,000 | 17,200 | 18.2 K to 17.2 K (-5.49 %) |
Apr 12 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 3.93 | 20,000 | 78,600 | 115,000 | |
Apr 12 2007 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | A | 3.93 | 20,000 | 78,600 | 165,000 | |
Apr 12 2007 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 3.93 | 20,000 | 78,600 | 165,000 | |
Apr 09 2007 | ARWR | ARROWHEAD PHARMACE ... | STEWART R BRUCE | President | Option Exercise | A | 4.34 | 250,000 | 1,085,000 | 825,000 | |
Apr 09 2007 | ARWR | ARROWHEAD PHARMACE ... | Kingsley Joseph Theodore III | Chief Financial Off ... | Option Exercise | A | 4.34 | 125,000 | 542,500 | 600,000 | |
Apr 09 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 4.58 | 1,000 | 4,576 | 18,200 | 19.2 K to 18.2 K (-5.21 %) |
Mar 22 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.80 | 453,400 | 1,722,920 | 742,600 | 1.2 M to 742.6 K (-37.91 %) |
Mar 22 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.80 | 68,000 | 258,400 | 166,778 | 234.8 K to 166.8 K (-28.96 %) |
Mar 22 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.80 | 428,500 | 1,628,300 | 1,292,281 | 1.7 M to 1.3 M (-24.90 %) |
Mar 22 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.80 | 210,100 | 798,380 | 497,300 | 707.4 K to 497.3 K (-29.70 %) |
Mar 22 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.82 | 45,800 | 174,942 | 1,196,000 | 1.2 M to 1.2 M (-3.69 %) |
Mar 22 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.82 | 6,800 | 25,974 | 234,778 | 241.6 K to 234.8 K (-2.81 %) |
Mar 22 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.82 | 43,450 | 165,966 | 1,720,781 | 1.8 M to 1.7 M (-2.46 %) |
Mar 22 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.82 | 21,200 | 80,978 | 707,400 | 728.6 K to 707.4 K (-2.91 %) |
Mar 22 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.81 | 52,300 | 199,179 | 1,241,800 | 1.3 M to 1.2 M (-4.04 %) |
Mar 22 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.81 | 7,800 | 29,706 | 241,578 | 249.4 K to 241.6 K (-3.13 %) |
Mar 22 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.81 | 49,400 | 188,135 | 1,764,231 | 1.8 M to 1.8 M (-2.72 %) |
Mar 22 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.81 | 24,200 | 92,163 | 728,600 | 752.8 K to 728.6 K (-3.21 %) |
Mar 20 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.93 | 9,600 | 37,728 | 1,294,100 | 1.3 M to 1.3 M (-0.74 %) |
Mar 20 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 3.93 | 340 | 1,336 | 249,378 | 249.7 K to 249.4 K (-0.14 %) |
Mar 19 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 4.11 | 26,800 | 110,033 | 1,303,700 | 1.3 M to 1.3 M (-2.01 %) |
Mar 19 2007 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Sell | S | 4.11 | 882 | 3,621 | 249,718 | 250.6 K to 249.7 K (-0.35 %) |
Mar 06 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 3.75 | 1,000 | 3,750 | 19,200 | 20.2 K to 19.2 K (-4.95 %) |
Feb 23 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 3.98 | 500 | 1,990 | 20,200 | 20.7 K to 20.2 K (-2.42 %) |
Feb 09 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 4.04 | 500 | 2,020 | 20,700 | 21.2 K to 20.7 K (-2.36 %) |
Jan 24 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 4.01 | 500 | 2,005 | 21,200 | 21.7 K to 21.2 K (-2.30 %) |
Jan 11 2007 | ARWR | ARROWHEAD PHARMACE ... | Kingsley Joseph Theodore III | Interim President & ... | Buy | P | 4.18 | 2,000 | 8,353 | 12,000 | 10 K to 12 K (+20.00 %) |
Jan 18 2007 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Sell | S | 4.01 | 500 | 2,005 | 21,700 | 22.2 K to 21.7 K (-2.25 %) |
Aug 18 2006 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Buy | P | 4.88 | 4,300 | 20,984 | 4,300 | 0 to 4.3 K |
Aug 18 2006 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Buy | P | 4.88 | 19,000 | 92,720 | 752,800 | 733.8 K to 752.8 K (+2.59 %) |
Aug 18 2006 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Buy | P | 4.88 | 74,450 | 363,316 | 1,813,631 | 1.7 M to 1.8 M (+4.28 %) |
Aug 18 2006 | ARWR | ARROWHEAD PHARMACE ... | KNOTT DAVID M | 10% Owner | Buy | P | 4.88 | 4,500 | 21,960 | 44,800 | 40.3 K to 44.8 K (+11.17 %) |
Aug 08 2006 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 5.24 | 25,000 | 131,000 | 170,000 | |
Aug 08 2006 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 5.02 | 10,000 | 50,200 | 145,000 | |
Aug 02 2006 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | A | 5.02 | 25,000 | 125,500 | 170,000 | |
Aug 02 2006 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | A | 5.02 | 10,000 | 50,200 | 145,000 | |
Aug 02 2006 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 5.26 | 25,000 | 131,500 | 120,000 | |
Aug 02 2006 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 5.02 | 10,000 | 50,200 | 95,000 | |
Aug 02 2006 | ARWR | ARROWHEAD PHARMACE ... | Kingsley Joseph Theodore III | President and CFO | Option Exercise | A | 5.24 | 75,000 | 393,000 | 475,000 | |
Aug 02 2006 | ARWR | ARROWHEAD PHARMACE ... | STEWART R BRUCE | Chief Executive Off ... | Option Exercise | A | 5.24 | 75,000 | 393,000 | 575,000 | |
Nov 21 2005 | ARWR | ARROWHEAD PHARMACE ... | Ekchian Leon | President | Option Exercise | A | 3.90 | 750,000 | 2,925,000 | 750,000 | |
Jun 27 2005 | ARWR | ARROWHEAD PHARMACE ... | Ching Marshall Robert | 10% Owner | Buy | U | 3.00 | 28,666 | 85,998 | 28,666 | 0 to 28.7 K |
Jun 27 2005 | ARWR | ARROWHEAD PHARMACE ... | Ching Marshall Robert | 10% Owner | Buy | U | 3.00 | 53,864 | 161,592 | 91,364 | 37.5 K to 91.4 K (+143.64 %) |
Jun 27 2005 | ARWR | ARROWHEAD PHARMACE ... | Ching Marshall Robert | 10% Owner | Buy | U | 3.00 | 158,046 | 474,138 | 195,546 | 37.5 K to 195.5 K (+421.46 %) |
Jun 27 2005 | ARWR | ARROWHEAD PHARMACE ... | Ching Marshall Robert | 10% Owner | Sell | U | 3.00 | 269,242 | 807,726 | 2,627,066 | 2.9 M to 2.6 M (-9.30 %) |
Jun 14 2005 | ARWR | ARROWHEAD PHARMACE ... | Ching Marshall Robert | 10% Owner | Option Exercise | D | 1.50 | 1,829,487 | 2,744,231 | 2,896,308 | |
Jun 14 2005 | ARWR | ARROWHEAD PHARMACE ... | Ching Marshall Robert | 10% Owner | Option Exercise | D | 1.50 | 37,500 | 56,250 | 37,500 | |
Jun 14 2005 | ARWR | ARROWHEAD PHARMACE ... | Ching Marshall Robert | 10% Owner | Option Exercise | D | 1.50 | 37,500 | 56,250 | 37,500 | |
May 27 2005 | ARWR | ARROWHEAD PHARMACE ... | RAHN LEROY T | Director | Option Exercise | A | 2.52 | 50,000 | 126,000 | 110,000 | |
May 27 2005 | ARWR | ARROWHEAD PHARMACE ... | Kingsley Joseph Theodore III | Chief Financial Off ... | Option Exercise | A | 2.52 | 100,000 | 252,000 | 400,000 | |
May 27 2005 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Option Exercise | A | 2.52 | 50,000 | 126,000 | 85,000 | |
May 27 2005 | ARWR | ARROWHEAD PHARMACE ... | STEWART R BRUCE | President | Option Exercise | A | 2.52 | 250,000 | 630,000 | 500,000 | |
May 27 2005 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | A | 2.52 | 50,000 | 126,000 | 110,000 | |
May 20 2005 | ARWR | ARROWHEAD PHARMACE ... | Kingsley Joseph Theodore III | Chief Financial Off ... | Buy | P | 2.62 | 10,000 | 26,191 | 10,000 | 0 to 10 K |